AGY - ALLERGY THERAPEUTICS - Share Chat

Allergy Therapeutics plc is a UK-based biopharmaceutical company focused on the development and commercialisation of allergen-specific immunotherapies for the diagnosis and treatment of allergies. Listed on AIM, the company offers a portfolio of subcutaneous (SCIT) and sublingual (SLIT) allergy vaccines, with established sales across Europe. A key part of its strategy involves advancing its novel peanut allergy vaccine candidate, PQ, leveraging its virus-like particle (VLP) platform. While the company has a strong scientific foundation and a promising pipeline, it has recently navigated significant financial challenges, leading to various fundraising initiatives and a comprehensive strategic review exploring options including asset divestment or a sale of the entire business to secure its long-term future and fund its R&D.